-
Moderna expects to start late-stage COVID-19 vaccine trial on July 27
expresspharma
July 16, 2020
Moderna said it will conduct the trial at 87 study locations, all in the U.S.
-
Zydus starts human trials of ZyCoV-D, its COVID-19 vaccine
expresspharma
July 16, 2020
The company will be enrolling over 1000 subjects across multiple clinical study sites in India for Adaptive Phase I/ II clinical trials.
-
Positive news on Oxford/AstraZeneca COVID-19 vaccine could come soon: ITV
expresspharma
July 16, 2020
The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results.
-
FDA grants fast track status to Pfizer and BioNTech Covid-19 vaccines
pharmaceutical-technology
July 15, 2020
Pfizer and BioNTech have received fast track designation from the US Food and Drug Administration (FDA) for two of their four potential Covid-19 vaccines.
-
Bharat Biotech starts human trials for Covaxin, India’s first COVID-19 vaccine
expresspharma
July 15, 2020
The company had earlier received approval from the Drug Controller General of India (DCGI) to conduct phase I and II human clinical trials.
-
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA
prnasia
July 14, 2020
Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"; stock code: 600196.SH, 02196.HK) is a leading healthcare group in China.
-
FDA grants Fast Track designation to two COVID-19 vaccines
europeanpharmaceuticalreview
July 14, 2020
Two investigational SARS-CoV-2 vaccine candidates, BNT162b1 and BNT162b2, currently in clinical trials have been granted Fast Track designation by the FDA.
-
Moderna and ROVI Ink Fill-Finish Deal
contractpharma
July 14, 2020
Collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate.
-
Pfizer, BioNTech’s coronavirus vaccine candidates get US FDA’s ‘fast track’ status
expresspharma
July 14, 2020
The market is “desperate to latch onto any positive developments in the vaccine field,” JP Morgan analyst Cory Kasimov said in a note.
-
Moderna teams up with ROVI to provide Covid-19 vaccine outside US
pharmaceutical-technology
July 13, 2020
US-based biotechnology firm Moderna has partnered with European pharmaceutical company Laboratorios Farmacéuticos Rovi (ROVI) for finish-fill manufacturing of its Covid-19 vaccine candidate, mRNA-1273.